/DEMANT.CO
DEMANT.CO Stock - Demant A/S
Healthcare|Medical - DevicesCPH
$214.00+0.85%
+$1.80 (+0.85%) • Dec 23
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.29
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $235.40
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DEMANT.CO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$211.86 – $216.14
TARGET (TP)$246.10
STOP LOSS$196.88
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.92
52W High$294.20
52W Low$202.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $22.42B | $22.44B | $19.70B | $18.39B | $14.47B |
| Gross Profit | $17.09B | $16.54B | $14.67B | $13.75B | $10.19B |
| Gross Margin | 76.2% | 73.7% | 74.4% | 74.8% | 70.4% |
| Operating Income | $4.71B | $4.15B | $3.21B | $3.44B | $1.53B |
| Net Income | $2.39B | $1.79B | $2.08B | $2.51B | $1.12B |
| Net Margin | 10.6% | 8.0% | 10.6% | 13.7% | 7.7% |
| EPS | $11.10 | $8.04 | $9.21 | $10.70 | $4.68 |
Company Overview
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
DEMANT.COBeat Rate
33%
Last 12 quarters
Avg Surprise
+8.4%
EPS vs Estimate
Beats / Misses
4/8
Last 12 quarters
Latest EPS
$5.28
Q3 2025
EPS Surprise History
Q4 21
+3.4%
$5.76vs$5.57
Q2 22
-8.0%
$4.60vs$5.00
Q1 23
-6.9%
$4.61vs$4.95
Q4 23
-42.6%
$2.60vs$4.53
Q2 24
-8.9%
$5.44vs$5.97
Q3 24
+2.7%
$5.99vs$5.83
Q2 25
-10.2%
$5.53vs$6.16
Q3 25
-7.4%
$5.28vs$5.70
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 3, 2026 | — | — | — | — |
Q3 2025 | Aug 12, 2025 | $5.70 | $5.28 | -7.4% | ✗ MISS |
Q2 2025 | May 29, 2025 | $6.16 | $5.53 | -10.2% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $5.83 | $5.99 | +2.7% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $5.97 | $5.44 | -8.9% | ✗ MISS |
Q4 2023 | Nov 7, 2023 | $4.53 | $2.60 | -42.6% | ✗ MISS |
Q1 2023 | Feb 7, 2023 | $4.95 | $4.61 | -6.9% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $5.00 | $4.60 | -8.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | $5.57 | $5.76 | +3.4% | ✓ BEAT |
Q2 2021 | Jun 30, 2021 | $4.91 | $4.94 | +0.6% | ✓ BEAT |
Q4 2020 | Dec 31, 2020 | $4.19 | $4.18 | -0.2% | ✗ MISS |
Q2 2020 | Jun 30, 2020 | $-0.58 | $0.50 | +184.9% | ✓ BEAT |
Q4 2019 | Dec 31, 2019 | $3.07 | $2.88 | -6.2% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $3.12 | — | — |
Q4 2018 | Dec 31, 2018 | — | $3.77 | — | — |
Q2 2018 | Jun 30, 2018 | — | $3.55 | — | — |
Q4 2017 | Dec 31, 2017 | — | $3.75 | — | — |
Q2 2017 | Jun 30, 2017 | — | $3.09 | — | — |
Q4 2016 | Dec 31, 2016 | — | $3.16 | — | — |
Q2 2016 | Jun 30, 2016 | — | $2.37 | — | — |
Latest News
Loading news...
Frequently Asked Questions about DEMANT.CO
What is DEMANT.CO's current stock price?
Demant A/S (DEMANT.CO) is currently trading at $214.00 per share. The stock has moved +0.85% today.
What is the analyst price target for DEMANT.CO?
No analyst price targets are currently available for this stock.
What sector is Demant A/S in?
Demant A/S operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the CPH exchange.
What is DEMANT.CO's market cap?
Demant A/S has a market capitalization of $45.27 billion, making it a large-cap company.
Does DEMANT.CO pay dividends?
No, Demant A/S does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALK-B.CO
ALK-Abelló A/S
$227.60
Mkt Cap: $50.4B
AMBU-B.CO
Ambu A/S
$87.75
Mkt Cap: $23.4B
BAVA.CO
Bavarian Nordic A/S
$189.45
Mkt Cap: $14.8B
CHEMM.CO
ChemoMetec A/S
$683.50
Mkt Cap: $11.9B
GN.CO
GN Store Nord A/S
$104.25
Mkt Cap: $15.2B
HLUN-B.CO
H. Lundbeck A/S
$43.00
Mkt Cap: $34.1B
SMSMED.CO
Scandinavian Medical Solutions A/S
$4.75
Mkt Cap: $0.1B
VIRO.CO
ViroGates A/S
$12.05
Mkt Cap: $0.1B
ZEAL.CO
Zealand Pharma A/S
$483.00
Mkt Cap: $34.1B
Explore stocks similar to DEMANT.CO for comparison